Uğur Uslu

1.3k total citations · 1 hit paper
44 papers, 908 citations indexed

About

Uğur Uslu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Uğur Uslu has authored 44 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 17 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Uğur Uslu's work include CAR-T cell therapy research (21 papers), Immunotherapy and Immune Responses (13 papers) and Cutaneous Melanoma Detection and Management (7 papers). Uğur Uslu is often cited by papers focused on CAR-T cell therapy research (21 papers), Immunotherapy and Immune Responses (13 papers) and Cutaneous Melanoma Detection and Management (7 papers). Uğur Uslu collaborates with scholars based in Germany, United States and Türkiye. Uğur Uslu's co-authors include Carl H. June, Gerold Schuler, Bianca Simon, Jan Dörrie, Regina M. Young, Beatrice Schuler‐Thurner, Niels Schaft, Dennis Christoph Harrer, Nils W. Engel and Nils Wellhausen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Uğur Uslu

43 papers receiving 896 citations

Hit Papers

Beyond the blood: expanding CAR T cell therapy to solid t... 2024 2026 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uğur Uslu Germany 17 692 417 266 185 152 44 908
Premal Lulla United States 17 702 1.0× 290 0.7× 258 1.0× 231 1.2× 128 0.8× 64 938
Meng‐Fen Wu United States 11 948 1.4× 581 1.4× 164 0.6× 251 1.4× 93 0.6× 16 1.1k
Annelies Jorritsma Netherlands 12 776 1.1× 671 1.6× 320 1.2× 334 1.8× 64 0.4× 16 1.1k
Maria‐Luisa Schubert Germany 20 1.0k 1.5× 335 0.8× 397 1.5× 339 1.8× 291 1.9× 40 1.2k
Vicky Torrano United States 6 791 1.1× 389 0.9× 181 0.7× 187 1.0× 106 0.7× 9 893
Pranay D. Khare United States 10 408 0.6× 197 0.5× 193 0.7× 188 1.0× 139 0.9× 17 701
Justyna Ogonek Germany 11 504 0.7× 404 1.0× 214 0.8× 122 0.7× 149 1.0× 14 945
Anthony F. Daniyan United States 12 784 1.1× 363 0.9× 326 1.2× 237 1.3× 241 1.6× 24 1.0k
Nicoletta Cieri Italy 13 786 1.1× 708 1.7× 295 1.1× 237 1.3× 149 1.0× 31 1.3k
Zachary A. Borman United States 11 1.0k 1.5× 998 2.4× 298 1.1× 374 2.0× 164 1.1× 18 1.4k

Countries citing papers authored by Uğur Uslu

Since Specialization
Citations

This map shows the geographic impact of Uğur Uslu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uğur Uslu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uğur Uslu more than expected).

Fields of papers citing papers by Uğur Uslu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uğur Uslu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uğur Uslu. The network helps show where Uğur Uslu may publish in the future.

Co-authorship network of co-authors of Uğur Uslu

This figure shows the co-authorship network connecting the top 25 collaborators of Uğur Uslu. A scholar is included among the top collaborators of Uğur Uslu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uğur Uslu. Uğur Uslu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uslu, Uğur, Sofia Castelli, & Carl H. June. (2024). CAR T cell combination therapies to treat cancer. Cancer Cell. 42(8). 1319–1325. 49 indexed citations
2.
Castelli, Sofia, Uğur Uslu, Amanda Finck, et al.. (2023). 238 Potentiating CAR T cell therapy through synthetic IL-9R signaling. SHILAP Revista de lepidopterología. A274–A274. 1 indexed citations
3.
Young, Regina M., Nils W. Engel, Uğur Uslu, Nils Wellhausen, & Carl H. June. (2022). Next-Generation CAR T-cell Therapies. Cancer Discovery. 12(7). 1625–1633. 113 indexed citations
4.
Zelba, Henning, Teresa Amaral, Thomas Eigentler, et al.. (2019). Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade. PLoS ONE. 14(8). e0221301–e0221301. 14 indexed citations
5.
Simon, Bianca, Dennis Christoph Harrer, Christian Thirion, et al.. (2019). Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy. Journal of Immunological Methods. 472. 55–64. 16 indexed citations
6.
Moreira, Alvaro, Stefanie Groß, Uğur Uslu, et al.. (2019). Dendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses.. Journal of Clinical Oncology. 37(15_suppl). e21024–e21024. 3 indexed citations
8.
Uslu, Uğur, et al.. (2019). Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?. Acta Dermato Venereologica. 99(10). 889–893. 17 indexed citations
10.
Simon, Bianca, Dennis Christoph Harrer, Beatrice Schuler‐Thurner, et al.. (2018). The siRNA‐mediated downregulation of PD‐1 alone or simultaneously with CTLA‐4 shows enhanced in vitro CAR‐T‐cell functionality for further clinical development towards the potential use in immunotherapy of melanoma. Experimental Dermatology. 27(7). 769–778. 52 indexed citations
11.
Uslu, Uğur, et al.. (2018). Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations. European Journal of Dermatology. 28(3). 364–369. 3 indexed citations
12.
Schliep, Stefan, et al.. (2018). Eosinophilic polymorphic and pruritic eruption associated with radiotherapy: case report and overview of disease characteristics. Clinical and Experimental Dermatology. 44(5). 567–569.
14.
Uslu, Uğur, et al.. (2017). Intracorneal Hematoma Showing Clinical and Dermoscopic Features of Acral Lentiginous Melanoma. Case Reports in Dermatological Medicine. 2017. 1–3. 2 indexed citations
15.
Uslu, Uğur, Michael Erdmann, Stefan Schliep, & Michael Sticherling. (2017). Crusted Nodules on the Lower Left Arm in a Traveller Returning from South America: A Quiz. Acta Dermato Venereologica. 98(1). 159–160. 1 indexed citations
16.
Uslu, Uğur, et al.. (2016). Effectiveness of an employee skin cancer screening program for secondary prevention.. PubMed. 98(2). 113–9. 4 indexed citations
17.
Uslu, Uğur, Gerold Schuler, Jan Dörrie, & Niels Schaft. (2016). Combining a chimeric antigen receptor and a conventional T‐cell receptor to generate T cells expressing two additional receptors (TETARs) for a multi‐hit immunotherapy of melanoma. Experimental Dermatology. 25(11). 872–879. 30 indexed citations
18.
Oruç, Ertan & Uğur Uslu. (2006). [Comparative cytopathological and histopathological studies of sheep with suspected Coenurus cerebralis infection].. PubMed. 30(4). 285–8. 3 indexed citations
19.
Sevinç, Ferda, et al.. (2005). The prevalence of Cryptosporidium parvum in lambs around Konya. TURKISH JOURNAL OF VETERINARY AND ANIMAL SCIENCES. 29(5). 1191–1194. 10 indexed citations
20.
Sevinç, Ferda, et al.. (2005). Massive Cryptosporidium parvum Infection Associated with an Outbreak of Diarrhoea in Neonatal Goat Kids. TURKISH JOURNAL OF VETERINARY AND ANIMAL SCIENCES. 29(6). 1317–1320. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026